New Perspectives on Accelerating Genetic Nanomedicines Through the Regulatory Pathway

In hospitals across the country, life-saving medical devices hum along, year after year. Many of these machines have been trusted companions for more than a decade—reliable, familiar and, in some cases, irreplaceable. But beneath that reliability can lie hidden danger.

Battelle has developed a new polymer nanoparticle (PNP) delivery system that can target specific cell types, such as neuronal cells. The work, which was recently recognized as the “Best Poster” at the Controlled Release Society 2024 Annual Meeting in Italy, could pave the way for safer, more effective gene therapies for genetic diseases.

Transitioning from AFFF is a complex undertaking that touches every aspect of your operation. Here's how to choose a foam transition partner that can help you navigate complex change-outs with confidence.

In AFFF transitions, every decision can impact liability, performance, cost or operations. See how a strategic, risk-informed approach can reduce environmental exposure, strengthen compliance, support long-term resilience and help industrial operators make smarter, more confident decisions.

In the fast-evolving world of agriculture, formulation innovation is no longer optional—it’s essential. Agrochemical companies are under pressure to deliver crop protection products that are not only effective but also sustainable, user-friendly and compliant with increasingly complex regulations.